Depression and Anxiety Trial, Recruiting NCT05289258 Sponsor: Universidad de Córdoba Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT05289258
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with breast cancer at stage I, II, or III.
  • You finished your last chemotherapy session no less than 6 months ago and no more than 6 years ago.
  • You have some level of memory or thinking difficulties, but not severe — based on a specific memory and thinking test score (confirm with trial site).
  • You are fluent in Spanish.
  • You are not currently taking part in any other clinical trial.
  • You are not currently receiving any other type of psychological or talking therapy.

Who may not be able to join:

  • You are over 70 years old.
  • You have been diagnosed with stage IV cancer, or a type of cancer other than breast cancer.
  • Your last chemotherapy session was less than 6 months ago or more than 6 years ago.
  • Your memory and thinking test results show no cognitive problems (confirm with trial site).
  • You had a diagnosed mental health condition or substance use disorder before your cancer diagnosis.
  • Your cancer has come back after completing chemotherapy.
  • You have a diagnosed neurodevelopmental condition (such as ADHD or autism — confirm with trial site).
  • You have certain other health conditions that can affect memory or thinking, such as diabetes, epilepsy, dementia, multiple sclerosis, stroke, sleep apnea, HIV, or others (confirm with trial site for the full list).
  • You take certain medications that can affect thinking and memory, such as some antidepressants, antipsychotics, or seizure medications (confirm with trial site for the full list).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Universidad de Córdoba
Registry
ClinicalTrials.gov
Start date
25 January 2021
Est. completion
30 December 2026

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Functional assessment of Cancer Therapy-Cognitive Function, version 3. (FACT-Cog).; Memory Failures Everyday (MFE-30).; Hopkins Verbal Learning Test-Revised (HVLT-R).; Trail Making Test (TMT).; Controlled Oral Word Association Test (COWAT).

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov